Prior lung disease and lung cancer risk in an occupational-based cohort in Yunnan, China

Lung Cancer

Volumn 72, Issue 2, 2011, Pages 258-263

  Fan, Ya Guang ^a   Jiang, Yong ^b   Chang, Run Sheng ^c   Yao, Shu Xiang ^d   Jin, Ping ^d   Wang, Wendy ^e   He, Jie ^b   Zhou, Qing hua ^a   Prorok, Philip ^e   Qiao, You Lin ^b   Hu, Ping ^e  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b CANCER HOSPITAL   (China)

^c Third People's Hospital of Honghe Autonomous District   (China)

^d KUNMING MEDICAL UNIVERSITY   (China)

^e NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Asthma; Bronchitis; Lung carcinoma; Lung diseases

Indexed keywords

ADULT; ASTHMA; CANCER RISK; CHINA; CHRONIC BRONCHITIS; FEMALE; HUMAN; LETTER; LUNG CANCER; LUNG DISEASE; LUNG SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL;

ADULT; AGED; AGED, 80 AND OVER; ASTHMA; BRONCHITIS; CARCINOMA, SMALL CELL; CARCINOMA, SQUAMOUS CELL; CHINA; CHRONIC DISEASE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; OCCUPATIONAL EXPOSURE; PROSPECTIVE STUDIES; QUESTIONNAIRES; RISK;

EID: 79953793333     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lungcan.2011.01.032     Document Type: Letter

References (45)

1. Herbst R.S., Heymach J.V., Lippman S.M. Lung cancer. N Engl J Med 2008, 359:1367-1380.
2. Wang J.B., Jiang Y., Wei W.Q., Yang G.H., Qiao Y.L., Boffetta P. Estimation of cancer incidence and mortality attributable to smoking in China. Cancer Causes Control 2010, 21:959-965.
3. Boffetta P., Agudo A., Ahrens W., Benhamou E., Benhamou S., Darby S.C., et al. Multicenter case-control study of exposure to environmental tobacco smoke and lung cancer in Europe. J Natl Cancer Inst 1998, 90:1440-1450.
4. Krewski D., Lubin J.H., Zielinski J.M., Alavanja M., Catalan V.S., Field R.W., et al. Residential radon and risk of lung cancer: a combined analysis of 7 North American case-control studies. Epidemiology 2005, 16:137-145.
5. Steenland K., Loomis D., Shy C., Simonsen N. Review of occupational lung carcinogens. Am J Ind Med 1996, 29:474-490.
6. Osann K.E., Lowery J.T., Schell M.J. Small cell lung cancer in women: risk associated with smoking prior respiratory disease and occupation. Lung Cancer 2000, 28:1-10.
7. Mayne S.T., Buenconsejo J., Janerich D.T. Previous lung disease and risk of lung cancer among men and women nonsmokers. Am J Epidemiol 1999, 149:13-20.
8. Wu A.H., Fontham E.T., Reynolds P., Greenberg R.S., Buffler P., Liff J., et al. Previous lung disease and risk of lung cancer among lifetime nonsmoking women in the United States. Am J Epidemiol 1995, 141:1023-1032.
9. Alavanja M.C., Brownson R.C., Boice J.D., Hock E. Preexisting lung disease and lung cancer among nonsmoking women. Am J Epidemiol 1992, 136:623-632.
10. Littman A.J., Thornquist M.D., White E., Jackson L.A., Goodman G.E., Vaughan T.L. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 2004, 15:819-827.
11. Brenner A.V., Wang Z., Kleinerman R.A., Wang L., Zhang S., Metayer C., et al. Previous pulmonary diseases and risk of lung cancer in Gansu province, China. Int J Epidemiol 2001, 30:118-124.
12. Brown D.W., Young K.E., Anda R.F., Giles W.H. Asthma and risk of death from lung cancer: NHANES II Mortality Study. J Asthma 2005, 42:597-600.
13. Gao Y.T., Blot W.J., Zheng W., Ershow A.G., Hsu C.W., Levin L.I., et al. Lung cancer among Chinese women. Int J Cancer 1987, 40:604-609.
14. Wu-Williams A.H., Dai X.D., Blot W., Xu Z.Y., Sun X.W., Xiao H.P., et al. Lung cancer among women in north-east China. Br J Cancer 1990, 62:982-987.
15. Wu A.H., Yu M.C., Thomas D.C., Pike M.C., Henderson B.E. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988, 48:7279-7284.
16. Samet J.M., Humble C.G., Pathak D.R. Personal and family history of respiratory disease and lung cancer risk. Am Rev Respir Dis 1986, 134:466-470.
17. Osann K.E. Lung cancer in women: the importance of smoking, family history of cancer, and medical history of respiratory disease. Cancer Res 1991, 51:4893-4897.
18. Biesalski H.K., Bueno de Mesquita B., Chesson A., Chytil F., Grimble R., Hermus R.J., et al. European consensus statement on lung cancer: risk factors and prevention. Lung cancer panel. CA Cancer J Clin 1998, 48:167-176.
19. Ratnasinghe D., Yao S.X., Tangrea J.A., Qiao Y.L., Andersen M.R., Barrett M.J., et al. Polymorphisms of the DNA repair gene xrcc1 and lung cancer risk. Cancer Epidemiol Biomarkers Prev 2001, 10:119-123.
20. Qiao Y.L., Taylor P.R., Yao S.X., Erozan Y.S., Luo X.C., Barrett M.J., et al. Risk factors and early detection of lung cancer in a cohort of Chinese tin miners. Ann Epidemiol 1997, 7:533-541.
21. Kreienbrock L., Kreuzer M., Gerken M., Dingerkus G., Wellmann J., Keller G., et al. Case-control study on lung cancer and residential radon in western Germany. Am J Epidemiol 2001, 153:42-52.
22. Mostafa M.G., McDonald J.C., Cherry N.M. Lung cancer and exposure to arsenic in rural Bangladesh. Occup Environ Med 2008, 65:765-768.
23. Sun L., Zhao G., Xuemin J.I., Li J., Xuan Q., Liu C., et al. Lung cancer induced by inhaled radon and its progeny in rats. Chin J Radiol Med Pro 1986, 6:159-161.
24. Kueppers F., Fallat R., Larson R.K. Obstructive lung disease and alpha-1-antitrypsin deficiency gene heterozygosity. Science 1969, 165:899-901.
25. Yang P., Wentzlaff K.A., Katzmann J.A., Marks R.S., Allen M.S., Lesnick T.G., et al. Alpha1-antitrypsin deficiency allele carriers among lung cancer patients. Cancer Epidemiol Biomarkers Prev 1999, 8:461-465.
26. Von Hertzen L., Leinonen M., Surcel H.-M., Karulamen J., Saikku P. Measurement of sputum antibodies in the diagnosis of acute and chronic respiratory infections associated with C. pneumoniae. Clin Diagn Lab Immunol 1995, 2:454-457.
27. Laurila A.L., Anttila T., Läärä E., Bloigu A., Virtamo J., Albanes D., et al. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int J Cancer 1997, 74:31-34.
28. Ballaz S., Mulshine J.L. The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 2003, 5:46-62.
29. Farrow D.C., Vaughan T.L., Sweeney C., Gammon M.D., Chow W.H., Risch H.A., et al. Gastroesophagealreflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000, 11:231-238.
30. Nomura A. Stomach cancer. Cancer Epidemiology and Prevention 1996, 707-724. Oxford University Press, New York. D. Schottenfeld, J.F. Fraumeni (Eds.).
31. Mills P.K., Beeson W.L., Fraser G.E., Phillips R.L. Allergy and cancer: organ site-specific results from the Adventist Health Study. Am J Epidemiol 1992, 136:287-295.
32. McDuffie H.H. Atopy and primary lung cancer. Histology and sex distribution. Chest 1991, 99:404-407.
33. Santillan A.A., Camargo C.A., Colditz G.A. A meta-analysis of asthma and risk of lung cancer (United States). Cancer Causes Control 2003, 14:327-334.
34. Vena J.E., Bona J.R., Byers T.E., Middleton E., Swanson M.K., Graham S. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 1985, 122:66-74.
35. Park S.K., Cho L.Y., Yang J.J., Park B., Chang S.H., Lee K.S., et al. Lung cancer risk and cigarette smoking, lung tuberculosis according to histologic type and gender in a population based case-control study. Lung Cancer 2010, 68:20-26.
36. Engels E.A., Shen M., Chapman R.S., Pfeiffer R.M., Yu Y.Y., He X., et al. Tuberculosis and subsequent risk of lung cancer in Xuanweim, China. Int J Cancer 2009, 124:1183-1187.
37. Ramanakumar A.V., Parent M.E., Menzies D., Siemiatycki J. Risk of lung cancer following nonmalignant respiratory conditions: evidence from two case-control studies in Montreal, Canada. Lung Cancer 2006, 53:5-12.
38. Bae J., Gwack J., Park S.K., Shin H.R., Chang S.H., Yoo K.Y. Cigarette smoking, alcohol consumption, tuberculosis and risk of lung cancer: the Korean multi-center cancer cohort study. J Prev Med Public Health 2007, 40:321-328.
39. Liang H.Y., Li X.L., Yu X.S., Guan P., Yin Z.H., He Q.C., et al. Facts and fiction of the relationship between preexisting tuberculosis and lung cancer risk: a systematic review. Int J Cancer 2009, 125:2936-2944.
40. Nalbandian A., Yan B.S., Pichugin A., Bronson R.T., Kramnik I. Lung carcinogenesis induced by chronic tuberculosis infection: the experimental model and genetic control. Oncogene 2009, 28:1928-1938.
41. Engels E.A. Inflammation in the development of lung cancer: epidemiological evidence. Expert Rev Anticancer Ther 2008, 8:605-615.
42. Yu I.T., Tse L.A., Leung C.C., Wong T.W., Tam C.M., Chan A.C. Lung cancer mortality among silicotic workers in Hong Kong - no evidence for a link. Ann Oncol 2007, 18:1056-1063.
43. Carta P., Aru G., Manca P. Mortality from lung cancer among silicotic patients in Sardinia: an update study with 10 more years of follow up. Occup Environ Med 2001, 58:786-793.
44. Kurihara N., Wada O. Silicosis and smoking strongly increase lung cancer risk in silica-exposed workers. Ind Health 2004, 42:303-314.
45. Lacasse Y., Martin S., Simard S., Desmeules M. Meta-analysis of silicosis and lung cancer. Scand J Work Environ Health 2005, 31:450-458.